Background & Aims Concurrent to development of more effective drugs for treatment of
hepatitis C virus (HCV) infection, there has been an increase in the incidence of …

Summary Background Electronic health records (EHRs) collate longitudinal data that can be
used to facilitate large‐scale research in patients with cirrhosis. However, there is no …

Background and Aims Electronic health record (EHR)‐based research allows the capture of
large amounts of data, which is necessary in NAFLD, where the risk of clinical liver …

Background and Aims Patients with cirrhosis are at increased risk of postoperative mortality.
Currently available tools to predict postoperative risk are suboptimally calibrated and do not …

Real‐world healthcare data, including administrative and electronic medical record
databases, provide a rich source of data for the conduct of pharmacoepidemiologic studies …

The term acute‐on‐chronic liver failure (ACLF) is intended to identify patients with chronic
liver disease who develop rapid deterioration of liver function and high short‐term mortality …

Background: The incidence and determinants of hepatic decompensation have been
incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in …

Background & Aims Statins decrease portal pressure in patients with cirrhosis and increase
survival times of patients who have bled from varices. However, statins can be hepatotoxic. It …

Background & Aims Infection with hepatitis virus C (HCV) is associated with an increased
risk of cardiovascular disease (CVD) events. It is not clear whether treatment with direct …

Portal vein tumor thrombus (PVTT) is a significant poor prognostic factor for hepatocellular
carcinoma (HCC). Patients with PVTT limited to a first‐order branch of the main portal vein …